Navigation Links
Island Abbey Foods Ltd™ Now Offering New Honibe® Honey Lozenges™ Flavour Variations for Both Adults and Children
Date:2/2/2013

Charlottetown, PE, Canada (PRWEB) February 01, 2013

Island Abbey Foods Ltd.™, a PEI based natural health product and specialty food producer, has announced today that their Honibe® Honey Lozenges™ product line will now be expanding with six new Honey Lozenges for adult and children’s health.

Honibe Honey Lozenges are the world's first lozenges made from 100% pure dried honey. Honey Lozenges are now available in pure honey formulations with added natural sources of Cinnamon, Blackcurrant and Cranberry + Blueberry, as well as, natural Menthol and Eucalyptus formulations with Cinnamon, Cherry, and Spearmint. These new Honey Lozenges are for the temporary relief of sore throat and nasal congestion. They are conveniently sized for easy transportation in pockets, briefcases, purses, etc. Island Abbey Foods will be featuring the new products on their online retail store at http://www.honibe.com for direct purchase.

“We are so excited to announce today that we are expanding our current Honibe Honey Lozenges line with new flavour and product variations for the natural health cough and cold category”, stated John Rowe, President of Island Abbey Foods Ltd. “In celebration of these new product launches, we are offering all Honibe customers a 25% off coupon for all online orders placed in the next month. Simply enter coupon code: HONEY4HEALTH in our online shopping cart to get your discount!”

Honibe Honey Lozenges are made with 100% pu
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Entia Biosciences Receives Patent for Use of Ergothioneine in Foods and Beverages
2. At-the-Market Offerings (ATM) of Life Sciences Companies Perform Well in Weak Follow-on Financing Environment of Third Quarter
3. iBio, Inc. Prices $10 Million Public Offering
4. Sequenom Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
5. Spherix Announces Registered Direct Offering of $1.15 Million
6. Neuralstem Announces Closing of $5.2-Million Registered Direct Offering
7. Elsevier Collaborates With Prophecy Healthcare to Enhance Its Staff Development Offerings for Healthcare Organizations
8. OncoSec Closes $7.75 Million Public Offering
9. Genesis Biopharma Announces Proposed Public Offering of Common Stock and Warrants
10. ScaleMatrix Leads the Way Unveiling the Industry’s First Transparent Pricing Tool in Private Cloud Offerings
11. BioMed Realty, L.P. Prices $250 Million Offering Of 4.25% Senior Unsecured Notes Due 2022
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)...  Neurotech Pharmaceuticals, Inc., announced today the first ... 2 clinical trial of NT-503 Encapsulated Cell Therapy ... choroidal neovascularization secondary to age related macular degeneration ... growth factor (VEGF) receptor protein continuously produced by ... proof-of-concept study will evaluate NT-503 ECT as a ...
(Date:9/2/2015)... ZIONA, Israel , September 2, 2015 /PRNewswire/ ... today announced the intent of the National Institute of Allergy ... of Health (NIH) within the Department of Health and Human ... be held in the United States ... of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as a ...
(Date:9/2/2015)... ... 02, 2015 , ... The TS5-Q is designed for myriad ... to analysis of athletic performance. Producing high-resolution slow-motion video , the TS5-Q ... process with the naked eye. , Slow motion sequences are commonly seen ...
(Date:9/1/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... Annual Global Investment Conference sponsored by H.C. Wainwright ... The St. Regis Hotel in New York, ... , Chief Executive Officer, will provide an overview of ...
Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2
... Mark Wahl, jettisoned last week from his position as ... (LTSB , is mum on the reasons for his ... (R-West Bend) cited the results of an audit of ... a spokesperson for Assembly Speaker John Gard (R-Peshtigo) said ...
... stocks continue to show strong growth, the rate of growth ... the market is catching up). , ,The Nasdaq Biotech ... percent versus the Nasdaq Composites growth of 33 percent and ... Amex Biotech index matches the high growth of the Nasdaq ...
... told me (actually, he told it to my 10-year-old daughter and she ... found a bottle with a cork in it. They opened it up ... for 150 years," the genie says. "I'll grant you each one wish ... first guy says: "I want a million dollars," so the genie immediately ...
Cached Biology Technology:Wahl Mute on Firing from Legislative IT Bureau -- but politics could be to blame 2Midwest Public-Sector Biotech Continues to Sizzle 2Women in Midwest IT Have to Fight, Work Harder 2Women in Midwest IT Have to Fight, Work Harder 3
(Date:8/25/2015)... CITY and BELLEVUE, Wash. ... leader in advanced robotic systems, announced today it will ... unmanned ground vehicle (UGV), at the National Tactical Officers ... The Guardian S is the first-ever ... culmination of years of research and in-field trials and ...
(Date:8/20/2015)... 20, 2015   Sensory, Inc ., a ... user experience and security of consumer electronics through ... that its TrulySecure™ is the first ... be FIDO Certified™. The FIDO (Fast ... the FIDO UAF (Universal Authentication Framework) 1.0 specifications, ...
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2
... at Washington University in St. Louis has proposed ... the early Earth's development rather than physical processes, ... Washington University assistant professor of geomicrobiology in the ... & Sciences, studying Cyanobacteria ?bacteria that use light, ...
... and Karolinska Institutet announced today that they have ... healthcare by accelerating the translation of basic genetic ... treatment. , During the next five years the ... expression in patients with atherosclerosis, breast cancer, rheumatoid ...
... of cardiac progenitor cells ?rare, specialized stem cells located ... ?has been shown by researchers at the University of ... are capable of differentiation into fully mature heart tissue. ... stem cells that have been programmed to form heart ...
Cached Biology News:Family trees of ancient bacteria reveal evolutionary moves 2Family trees of ancient bacteria reveal evolutionary moves 3Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance 2Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance 3UCSD team discovers specialized, rare heart stem cells in newborns 2UCSD team discovers specialized, rare heart stem cells in newborns 3